Home > Insider Trading > Filing (0001536874-13-000002)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1159019	Tribute Pharmaceuticals Canada Inc.	TBUFF	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1536874	Elora Financial Management Inc.	151 Steele Ave East Milton A6 L9T1Y1	Cfo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Share	Acquisiton	2013-02-27	62,500	$0.40	6,812,500	No	4	P	Indirect	Elora Financial Management Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Elora Financial Management Inc.

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Share	Warrant A	Acquisiton	2013-02-27	31,250	$0.50	31,250	$0.50
Common Share	Warrant B	Acquisiton	2013-02-27	31,250	$0.60	31,250	$0.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,250	2013-02-27	2015-02-27	No	4	P	Indirect
31,250	2013-02-27	2018-02-27	No	4	P	Indirect

Footnotes

Each whole Series A Warrant entitles the holder thereof to acquire one common share of the Company at any time during the period ending 24 months after the date of issuance at a price of US$0.50 per common share
Each whole Series B Warrant entitles the holder thereof to acquire one common share of the Company at a price of US$0.60 per share at any time during the period ending 60 months after the date of issuance. The terms of the Series B Warrants provide the Company with a right to call the Series B Warrants at a price of US$0.001 per warrant if certain conditions are met including the common shares of the Company trading at a volume weighted average price for 20 out of 30 consecutive trading days at a price which exceeds US$1.20 (subject to adjustment for stock splits, recapitalizations and other corporate transactions) with average daily volume during such period of at least US$30,000.